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The studies by Woods (1) on the relationship of p-aminobenzoic acid (PABA) 
to the growth inhibitory action of the sulfonamides for bacteria have provided 
a  useful tool for metabofic studies with PABA and related compounds such as 
pteroic acid and pteroylglutamic (synthetic folio) acid (PGA) which contain the 
PABA moiety (2, 3).  Demonstration of the growth inhibitory effect of sulfa- 
diazine on psittacosis virus (strain 6BC) (4) and the subsequent studies showing 
that this inhibitory action was antagonized by PABA and PGA (5)  suggested 
the  usefulness  of this  system for a  study of certain factors concerned in the 
growth of this virus.  The present communication reports the results of experi- 
ments on the effect of PABA, pteroic acid,  PGA,  and  related  compounds on 
sulfonamide inhibition of the growth of psittacosis virus and attempts  to use 
this phenomenon to study certain possible synthetic activities of this virus. 
Since certain  analogues of PGA  1 have recently become available,  it was of 
interest to test them for their effect on growth of the virus and for their influ- 
ence on the inhibitory action of the sulfonamides since, in other systems, some 
of them behave like PGA (2) and others act as PGA antagonists  (6, 7). 
Materials and Methods 
Psittacosis  virus (strain  6BC) which had been repeatedly passed in eggs by the yolk sac 
route was used.  A pool of infected yolk sacs was prepared in nutrient broth with a Waring 
blendor.  Aliquots were placed in sealed glass ampoules and stored in the dry ice cabinet to 
provide a uniform inoculum for use in the experiments.  This yolk sac suspension was titrated 
by injecting 0.25 ml. amounts of serial  tenfold dilutions into the yolk sac of 6 to 7 day old 
embryonated eggs.  The infected eggs were incubated at 35°C. for 10 days during which time 
deaths were recorded and the LDr0 titer calculated (8).  Deaths occurring during the first 48 
hours were considered traumatic and disregarded.  The day of death of the embryos showed 
an inverse correlation with the size of the infectious inoculum.  For subsequent experiment.% 
a dilution of the seed virus containing 10,000 LD~0 doses in 0.25 ml. was used. 
The various compounds to be tested were dissolved in sterile distilled water for injection. 
The sulfadiazine was obtained as a sterile solution of the sodium salt (NaSD) and dosage was 
* Aided by a grant from The National Foundation  for Infantile  Paralysis. 
S Senior Fellow in Medical Sciences of the National Research Council. 
a Obtained through the courtesy of Lederle Laboratories. 
285 286  PTEROYLGLUTAMIC  ACID AND  PSITTACOSIS VIRUS 
recorded in terms of NaSD.  Weighed  amounts of crystalline PABA, p-aminohippuric acid 
(PAHA), pteroic acid, glutamic acid, and PGA were placed in volumetric flasks with distilled 
water and a few drops of phenol red.  Sodium hydroxide (1 N) was slowly  added until  the acids 
dissolved.  The solutions were then sterilized in the autoclave at 10 pounds for 10 minutes and 
adjusted to volume with sterile distilled  water.  Other PGA derivatives were furnished as 
sterile salts and dissolved in sterile distilled water.  The dosages of these materials are listed 
in terms of the free acid. 
In the tests for sulfonamide antagonism, the  solutions of the antagonist and the NaSD 
were mixed just before their injection  unless otherwise noted.  These various materials were 
injected into the yolk sac in 0.2 5 ml. volumes, and, after an interval  of from one-half to I hour, 
the virus inoculum was injected by the same route.  Infectious controls and uninfected eggs 
injected with the various  compounds as a check on their toxicity  were included in each ex- 
periment. 
Eggs were candled daily and deaths recorded.  Yolk sacs of representative embryos dying 
during the observation period were examined for the presence of psittacosis elementary  bodies 
by examining smears stained with Macchiavello stain.  Some  yolk sacs were cultured on 
blood agar and in thioglycollate broth to exclude the presence of bacterial contaminants. 
PABA determinations  were done, as for sulfanilamide, by the method of Bratton and 
Marshall (9).  The method described for determinations on blood was used with yolk samples 
and that suggested for urine specimens with the allantoic fluid levels. 
Determination of the Minimal Experimental Inhibiting Dose of NaSD 
In order to determine the efficacy of the action of the various sulfonamide 
antagonists, it was necessary to determine the effective dose of NaSD.  Groups 
of eggs were injected with from 0.001 to 5.0 rag. of NaSD prior to infection  with 
10,000 LD60 of the virus.  The results are presented in Table I.  These data 
show  that  for  an infectious inoculum of  10,000 LDs0,  the  minimal effective 
inhibiting dose of NaSD was between 0.1 and 0.5 mg.  To insure that an ade- 
quate amount of NaSD was present, 2.5 mg. were used in the subsequent experi- 
ments on antagonism unless a range of test dosages was employed. 
Effect of PABA  and PGA on the Growth of Psittacosis Virus and Their 
Antagonistic Effect on Inhibition of Growth by NaSD 
Experiments were carried out to determine the range of activity of the antag- 
onistic action of PABA and PGA on the growth inhibition of psittacosis virus 
by NaSD.  These data are summarized in Table II. 
It is apparent that on a weight basis, PABA was more than 10 times as active 
as PGA.  However, if the molecular weights are taken into account, PABA is 
only slightly more than 3  times as potent as PGA.  This difference in mag- 
nitude approaches the range of experimental error for this test system.  PABA 
alone in doses up to 5 mg. and PGA to 10 mg. had no effect on the growth of the 
virus and no serious degree of toxicity for the chick embryos. 
A question that immediately arises is whether the activity of the PGA might 
be due to the fact that it was being broken down by the chick embryo with the 
release of PABA.  When PABA was injected into eggs via the yolk sac  route 
in doses as low as 0.5 mg., detectable levels could be measured in the yolk and HERBERT  R.  MORGAN  287 
allantoic fluids after 2, 4, 6, and 9 days.  With doses of PGA as large as 10 rag. 
per egg, the yolk and  allantoic fluids  contained no free PABA  after the  same 
TABLE I 
Dd~mination of tl~ Minimal Inhibiting Dose of NaSD on tl~ Growth of Psittacosis  Virus 
(Strain 6BC) in Eggs 
NsSD  No. of eggs  Survived 10 days* 
mg, 
5.0 
2.5 
1.25 
0.5 
0.I 
0.05 
0.01 
0 
24 
29 
29 
16 
25 
12 
22 
8 
psg ¢8n| 
96 
97 
9O 
82 
0 
0 
0 
0 
* 10,000 LD~ virus injected via yolk sac. 
TABLE II 
Effect oJ PAB  A and PGA on the Gro'wth  Inhibition of Psittavosis Virus (Strain 6BC) by NaSD 
NaSD  Inhibitor  No. of eggs  Survived I0 days* 
m&. 
2.5 
c¢ 
¢¢ 
¢¢ 
¢c 
¢¢ 
¢¢ 
0 
0 
mg. 
PABA  0.5 
"  0.05 
"  0.005 
"  0.001 
"  0.0005 
PGA  5.0 
"  0.5 
"  0.25 
"  0.01 
"  0.005 
--  0 
PABA  5.0 
PGA  10.0 
12 
11 
12 
9 
10 
12 
12 
11 
10 
9 
12 
8 
10 
0 
0 
0 
55 
100 
0 
0 
66 
100 
100 
92 
0 
0 
D~g C~:roL~t 
0  I  PABA  5.0  20  95 
0  I  PGA  10.0  19  95 
* 10,000 LDe virus injected v/a yolk sac. 
Not infected. 
intervals  of  time.  This  evidence  strongly  suggests  that  PGA  is  not  broken 
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is active per se as a  sulfonamide  antagonist.  PAHA  was  also  tested  and no 
sulfonamide antagonism was demonstrated. 
TABLE  III 
Comparison of the Antagonism of Sulfonamide Inhibition  of Psittacosis Virus  (Strain  6BC) 
by PABA and PGA 
NaSD  Inhibitor  No. of eggs  Survived  10 days* 
mg. 
0.5 
2.0 
5.0 
10.0 
25.0 
50.0 
0.5 
2.0 
5.0 
10.0 
25.0 
50.0 
0.5 
2.0 
5.0 
10.0 
25.0 
50.0 
0.5 
2.0 
5.0 
10.0 
25.0 
50.0 
0.5 
5.0 
0 
0 
0 
mg. 
PABA  0.01 
~t  c~ 
gc  ct 
PABA  0.05 
PGA  0.1 
t~  c~ 
cg  c~ 
t~  *~ 
PGA  0.5 
Ii  cc 
--  0 
--  0 
PABA  5.0 
PGA  10.0 
--  0 
7 
8 
6 
19 
13 
12 
5 
8 
8 
18 
11 
4 
7 
8 
6 
16 
i1 
18 
8 
7 
7 
20 
I0 
7 
16 
24 
8 
10 
16 
0 
0 
0 
47 
85 
100 
0 
0 
0 
0 
8 
100 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
82 
96 
0 
0 
0 
Drug Co~rols$ 
50.0  --  0  8  85 
0  PABA  5.0  26  95 
0  PGA  10.0  19  95 
* 10,000 LDso virus injected into yolk sac. 
:~ Not infected. 
Since penicillin has been shown to inhibit the growth of psittacosis virus (10), 
the effect of PABA  and PGA  on its action was  tested.  In doses of 5  rag.  of H]gRBERT  R.  MORGAN  289 
PABA and 5 rag. of PGA these compounds failed to show any effect on  the 
protective action of 500 units of penicillin which gave an 80 per cent survival 
rate in embryos infected with 10,000 LDs0 of psittacosis virus.  This provides 
additional evidence for the specific nature of the metabolic interrelationships 
of NaSD, PABA, and PGA in the growth of psittacosis virus. 
Since liver extract as well as PGA has an important relationship to pernicious 
anemia, liver extract was tested in doses of 4.2 units (purified, Lilly) for possible 
antagonism of 2.5 rag. NaSD and was shown to be without any effect on the 
action of the drug. 
Type of Sulfonamide Antagonism Produced by PABA and PGA 
The previous studies of sulfonamide antagonism with bacteria had shown that 
PABA exerted a competitive antagonism on the sulfonamides, i.e. the amount 
of antagonist required bore a  direct  relationship to the dose of sulfonamide 
used, while PGA exerted its effect without regard to the amount of sulfonamide 
present (2, 3).  It was of interest, therefore,  to  determine the  nature of the 
action of these antagonists in the system being studied.  Two doses of PABA 
and PGA, representing 2 and 10 times their minimal effective amounts for 2.5 
rag.  of NaSD,  were  therefore  tested  against increasing amounts  of NaSD. 
These data are presented in Table III. 
There is a direct relationship between the amount of SD used and the amount 
of PABA required to  antagonize its inhibitory effect which  demonstrates a 
competitive type of inhibition for PABA.  On the other hand, once an effective 
dose of PGA is given, the dose of NaSD may be increased as much as 50 times 
without overcoming this antagonistic effect:  Therefore, PGA exerts a  non- 
competitive type of antagonism. 
Effect of Other Components of PGA on Sulfonamide Action 
Since PGA is composed of glutamic acid, PABA, and the pteridine nucleus, 
it was of interest to test components other than PABA for sulfonamide antag- 
onism.  Glutamic acid and pteroic acid were available for testing.  The pteroic 
acid had been purified so that it contained only 0.026 per cent of free PABA 
and 7 per cent of other pterin materials as contaminants.  ~  Table IV presents 
the data obtained in these experiments. 
Results of these experiments show that glutamic acid in doses up to 10 mg. 
exerts no effect on the sulfonamide inhibition of virus growth while pteroic acid 
in 0.05 and 0.25 rag. amounts shows a  competitive antagonistic effect. 
Effects  of Certain  Analogues  of PGA  on  the Growth  of Psittacosis Virus and 
Its Inhibition  by  NaSD 
The following analogues of PGA were tested: pteroyldiglutamic acid, pteroyl 
~/-diglutamic acid, pteroyltriglutamic acid, pteroylaspartic acid, and 4-amino- 
Data furnished by Dr. C. W. Waller of the Lederle Laboratories. 290  PTEROY'LGLUTAMIC ACID AND PSITTACOSIS VIRUS 
pteroylglutamic acid.  Another folic acid  antagonist,  N-methylpteroic acid, 
was also tested (6).  The data are presented in Table V. 
In doses up to 2.5 rag. per egg, pteroyldiglutamic acid, pteroyl-~/-diglutamic 
acid and pteroyltriglutamic acid had  no effect on the  growth of  psittacosis 
virus.  These compounds produced sulfonamide antagonism for 2.5 rag. NaSD 
in amounts of 0.1 rag.  Therefore, they appeared to act in the same manner as 
PGA in sulfonamide antagonism.  However, pteroyl--c-diglutamic acid when 
TABLE IV 
Effect of Components of PGA on the Sulfonamide  Inhibition  of Psittacosis Virus 
SD  Inhibitor  No. of eggs  Survived  10 days* 
mg. 
2.5 
tt 
1.0 
2.5 
5.0 
10.0 
20.0 
2.5 
5.0 
10.0 
20.0 
1.0 
20.0 
0 
mg. 
Glutamicacid  1,0 
"  "  10.0 
"  "  20.0 
Pteroic acid  0.05 
t~  ~  ct 
Pteroic acid  O. 25 
~t  ~  ct 
0 
--  0 
--  0 
9 
9 
6 
12 
11 
11 
11 
12 
12 
12 
11 
11 
8 
8 
6 
prr cc~t 
89 
78 
83 
0 
0 
36 
73 
lOo 
0 
0 
0 
36 
lOo 
85 
0 
Drug con~rolJ~ 
11  82 
6  83 
6  IO0 
0  Glutamic acid 10.0 
20.0  --  0 
0  Pteroic acid  5.0 
* 10,000 LDs0 virus injected via yolk sac. 
Not infected. 
tested for sulfonamide antagonism produced deaths of the embryos from 2 to 
3 days later than those occurring with the other compounds.  This delay indi- 
cates that this compound was somewhat less active than the others as an antag- 
onist for NaSD. 
Pteroylaspartic acid failed to produce sulfonamide antagonism  in doses of 
0.1 rag. but did so in 0.5 mg. amounts.  In doses of 10 rag. it had no effect on 
the growth of the virus. 
The compound N-methylpteroic acid produced definite sulfonamide antag- 
onism only with doses of 5 rag.  This effect was probably due to the small HERBERT R.  MORGAN  291 
amounts of PABA present in this preparation.  It had no effect on the growth 
of the virus in 10 rag. amounts. 
Attempts to study the effect of 4-aminopteroylgiutamic acid on the growth 
of the virus were difficult since this compound produced deaths in from 5 to 10 
TABLE V 
Effect of Analogues of Folic Acid on the Growth of Psittacosis Viru~ and Its Inhibition by NarD 
NaSD 
~&. 
2.5 
ct 
cc 
ct 
tc 
¢¢ 
c: 
c~ 
c~ 
~c 
ct 
~t 
0 
0 
0 
0 
0 
2.5 
0 
Inhibitor 
mg, 
Pteroylglutamic acid  0.1 
"  "  0.5 
Pteroyldiglutamic  acid  0.1 
"  "  0.5 
Pteroyl-~-diglutamic acid  0.1 
"  "  0.5 
Pteroyltriglutamic  acid  0.1 
"  "  0.5 
Pteroylaspartic  acid  0.1 
"  "  0.5 
N-methylpteroic  acid  0.5 
....  5.0 
Pteroyldiglutamic  acid  2.5 
Pteroyl--t-diglutamic  acid  2.5 
Pteroyltriglutamic  acid  2.5 
Pteroylaspartic  acid  10.0 
N-methylpteroic  acid  10.0 
0 
0 
Survlved  I0  No.  of  eggs  days* 
per ¢~nt 
8  0 
I0  0 
10  10 
9  0 
10  0 
I0  0 
8  0 
10  0 
10  50 
10  0 
6  66 
8  0 
8  0 
8  0 
8  0 
6  0 
7  0 
12  100 
12  0 
Drug  cor~rols~ 
Pteroyldiglutamic  acid  2.5 
Pteroyl-~--diglutamic acid  2.5 
Pteroyltriglutamic  acid  2.5 
Pteroylaspartic acid  10.0 
N-methylpteroic acid  10.0 
10 
10 
10 
9 
10 
I00 
I00 
90 
75 
I00 
* 10,000 LDso virus injected ~/a yolk sac. 
Not infected. 
days in chick embryos when given in doses of 0.001 to 0.005 rag.  When virus- 
infected eggs were given 3 injections of 0.002 mg. over a period of 7 ~ays and 
the yolk sacs were harvested and titrated,  the content of virus was about the 
same as in untreated  and infected controls.  Small doses of 4-aminopteroyl- 
glutamic acid (0.002  mg.)  combined with 0.25  to 0.01  mg.  of NaSD  gave no 
evidence  of potentiating  nor  antagonizing  the  virus-inhibiting  action of  the 292  PTEROYLGLUTA~IC  ACID  AND  PSITTACOSIS  VIRUS 
sulfonamide.  Within the limitations of these experimental techniques no effect 
of 4-aminopteroylglutamic acid on virus growth could be demonstrated. 
DISCUSSION 
Among the members of the psittacosis-lymphogranuloma group, the viruses 
of lymphogranuloma venereum (11), mouse pneumonitis (11), and at least two 
strains of psittacosis virus, i.e. 6BC (4) and Gleason (12), have been shown to 
be susceptible to the chemotherapeutic action of sulfonamide drugs.  Studies 
on the antagonistic action of PABA on the sulfonamide inhibition of growth 
of lymphogranuloma venereum virus have yielded conflicting results.  Findlay 
(13) reported that PABA antagonized the chemotherapeutic action of sulfanil- 
amide in mice infected with this virus that received 10 rag. of each compound 
daily.  In direct contrast, Seeler et al.  (14) using a diet containing 0.3 per cent 
PABA and 0.3 per cent sulfanilamide were unable to demonstrate any effect of 
PABA.  Rodaniche (15) feeding a diet containing 0;5 per cent PABA and 2 per 
cent sulfathiazole found no effect, but noted some evidence of sulfonamide 
antagonism when the amount of PABA was increased to 2 per cent. 
The discrepancies in the results previously reported may be due to the fact 
that PABA is rapidly excreted by the mouse (16) so that it may not have been 
present in the body in adequate amounts. 
The data presented here show clearly that PABA will antagonize the inhibi- 
tion of psittacosis virus growth by the sulfonamides.  The further demonstra- 
tion that PGA has a similar action has provided a useful tool for the investi- 
gation  of  possible  metabolic  activities  and  growth  requirements  of  the 
psittacosis virus. 
Demonstration of the competitive nature of the sulfonamide antagonism by 
PABA, and, the finding that once an adequate dose of PGA is given, the sul- 
fonamide dosage may be increased without any effect have certain interesting 
implications.  If the systems which have been worked out in the case of several 
bacteria (2, 3) can be applied here, then it can be reasoned that the sulfonamide 
prevents the growth of psittacosis virus by interfering with its use of PABA in 
the synthesis of PGA which it requires for growth.  This reasoning is based on 
the fact that PABA can competitively reverse the growth inhibitory action of 
the sulfonamide.  Furthermore, once PGA is supplied, the virus can grow in 
the presence of large amounts of NaSD since this essential metabolite is fui-- 
nished.  Further evidence for this hypothesis is presented in the data obtained 
with the experiments using glutamic and pteroic  acids.  Glutamic acid,  as 
expected, was found to be without effect on sulfonamide action.  On the other 
hand, pteroic acid antagonized sulfonamide inhibition of virus growth in a com- 
petitive manner.  This finding suggests that pteroic acid is an intermediate 
step in the synthesis of PGA by psittacosis virus. 
Of course, it could be pointed out that these effects might be operating on the H~RBERT  R.  MORGAN  293 
host rather than the virus, but there is evidence that chicks do not synthesize 
PGA since it is a dietary requirement for them (17). 
Of the analogues tested, all but pteroylaspartic acid, 4-aminopteroylglutamic 
acid,  and N-methylpteroic acid have previously been  shown  to  have prop- 
erties similar to those of PGA.  Similar  data were obtained in these experi- 
ments.  The  compounds  4-aminopteroylglutamic  acid  and  N-methylpteroic 
acid are known to be active antagonists for PGA (6).  In this study, they dif- 
fered from PGA in that they showed no activity as sulfonamide antagonists. 
Within the limitations of this experimental technique, they showed no inhibitory 
effect on psittacosis viAts growth.  However, they did kill the chick embryos 
and histological examination of their erythropoietic tissue showed a marked 
maturation arrest which could be reversed by the administration of PGA (18). 
These findings  suggest that these compounds were active as folic acid antag- 
onists in the chick embryo tissues.  Therefore, the fact that, in the small doses 
that could be tolerated, they did not affect growth of the psittacosis in these 
tissues may provide additional evidence that the virus was synthesizing its own 
PGA since it would not then be affected by their action.  Obviously, if the virus 
is capable of synthesizing PGA, it should be present in higher concentrations in 
infected chick tissues and fluids in comparison with the same materials  from 
normal embryos.  Experiments are now underway to elucidate this point. 
It is of special interest that these experiments give evidence of the relation- 
ship of PGA to growth of this virus since recent studies (19) have suggested that 
this compound has an important r61e in the synthesis of nucleic acids and certain 
of their derivatives which are important factors in the chemical constitution of 
viruses. 
S~/kRY  AND CONCLUSIONS 
p-Aminobenzoic  and pteroic acids antagonize the inhibition of the growth of 
psittacosis virus (strain 6BC) by sulfadiazine  in a competitive manner.  Pter- 
oylglutamic acid exerts a non-competitive type sulfonamide  antagonism. 
The effects of certain analogues of pteroylglutamic acid and of pteroic acid 
on the growth of psittacosis virus and its inhibition by sulfadiazine  are reported. 
The implications of these findings  with regard to the possible synthesis of 
pteroylglutamic acid by psittacosis virus and its suggested r61e as an essential 
factor for growth of this virus are discussed. 
The author gratefully acknowledges the technical assistance of Mrs. Virginia Peaslee. 
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